Pilot Evaluation of Hospice Decision Support Tools
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 65 - Any |
| Updated: | 1/9/2019 |
| Start Date: | July 15, 2018 |
| End Date: | March 31, 2020 |
| Contact: | Channing E. Tate, MPH |
| Email: | channing.tate@ucdenver.edu |
| Phone: | 303-724-8985 |
The goal of this project is to determine the feasibility and acceptability of a hospice
decision aid among a diverse population of older adults at multiple stages of illness (Aim 1)
and to determine the preliminary efficacy of the hospice decision aid on decision quality,
hospice knowledge, and values-concordance (Aim 2). By testing the feasibility, acceptability,
and preliminary efficacy of a novel hospice PtDA in a diverse population of older adults,
additionally the study will simultaneously explore barriers to PtDA implementation in both an
outpatient primary care and inpatient palliative care setting. The study will also gather
sufficient pilot data to support a subsequent effectiveness/implementation trial and thus
address the absence of quality of SDM interventions for end-of-life care decision-making.
decision aid among a diverse population of older adults at multiple stages of illness (Aim 1)
and to determine the preliminary efficacy of the hospice decision aid on decision quality,
hospice knowledge, and values-concordance (Aim 2). By testing the feasibility, acceptability,
and preliminary efficacy of a novel hospice PtDA in a diverse population of older adults,
additionally the study will simultaneously explore barriers to PtDA implementation in both an
outpatient primary care and inpatient palliative care setting. The study will also gather
sufficient pilot data to support a subsequent effectiveness/implementation trial and thus
address the absence of quality of SDM interventions for end-of-life care decision-making.
Inclusion Criteria:
- 65 or older.
- At least one life-limiting illness or syndrome.
Exclusion Criteria:
- Non-English speakers.
- Patients with cognitive Impairments preventing ability to provide informed consent.
- Patients on isolation precautions due to resistant bacteria or impaired immune
function.
We found this trial at
1
site
13001 E. 17th Pl
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
Phone: 303-724-8985
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
Click here to add this to my saved trials
